{"id":"glycopyrronium-topical-wipes","safety":{"commonSideEffects":[{"rate":null,"effect":"Dry skin"},{"rate":null,"effect":"Irritation at application site"},{"rate":null,"effect":"Pruritus"}]},"_chembl":{"chemblId":"CHEMBL1201027","moleculeType":"Small molecule","molecularWeight":"398.34"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Glycopyrronium works by antagonizing muscarinic M3 receptors on eccrine sweat glands, thereby decreasing acetylcholine-mediated sweat production. When applied topically as a wipe formulation, it provides localized antiperspirant effects without significant systemic absorption. This mechanism makes it suitable for treating hyperhidrosis (excessive sweating) in specific body areas.","oneSentence":"Glycopyrronium is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce sweat gland secretion.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:14:06.842Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary hyperhidrosis (excessive sweating)"}]},"trialDetails":[{"nctId":"NCT02129660","phase":"PHASE2","title":"Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2014-04","conditions":"Hyperhidrosis","enrollment":105},{"nctId":"NCT02553798","phase":"PHASE3","title":"Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2015-08","conditions":"Hyperhidrosis","enrollment":564},{"nctId":"NCT02530294","phase":"PHASE3","title":"Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2015-08","conditions":"Hyperhidrosis","enrollment":353},{"nctId":"NCT02530281","phase":"PHASE3","title":"Study of Glycopyrronium in Axillary Hyperhydrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2015-07","conditions":"Hyperhidrosis","enrollment":344}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DRM04"],"phase":"phase_3","status":"active","brandName":"glycopyrronium Topical Wipes","genericName":"glycopyrronium Topical Wipes","companyName":"Journey Medical Corporation","companyId":"journey-medical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glycopyrronium is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce sweat gland secretion. Used for Primary hyperhidrosis (excessive sweating).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}